These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1157063)

  • 1. [Complex effect of mercurascan on ischaemia-induced myocardial injury].
    Málek P; Kolc J; Vrána M; Kucerová V; Mrhová O; Vránová Z
    Cas Lek Cesk; 1975 Jun; 114(25):753-7. PubMed ID: 1157063
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the therapeutic use of mercurascan (MSC). Part 1: Distribution of mercurascan in the body in experimental and clinical myocardial ischaemia.
    Málek P; Vavrejn B; Kolc J; Ratuský J
    Int J Clin Pharmacol; 1974 Dec; 10(4):266-72. PubMed ID: 4443131
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the therapeutic use of mercurascan (MSC). Part 2: Antiarrhythmogenic and haemodynamic effect of MSC in experimental myocardial ischaemia.
    Málek P; Vrána M; Kolc J; Netusil M; Blazek Z
    Int J Clin Pharmacol; 1974 Dec; 10(4):273-82. PubMed ID: 4140846
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the therapeutic use of Mercurascar. Part IV: The effect of Mercurascan on some metabolic changes in experimental myocardial ischaemia. Section II: Enzymes.
    Mrhová O; Kolc J; Málek P
    Int J Clin Pharmacol Biopharm; 1975 Jan; 11(1):52-7. PubMed ID: 125244
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the therapeutic use of Mercurascar. Part III. Influence of Mercurascan on some metabolic changes in experimental myocardial ischaemia in dogs. Section I: Energetic and ionic metabolism.
    Kucerová V; Kolc J; Málek P
    Int J Clin Pharmacol Biopharm; 1975 Jan; 11(1):40-51. PubMed ID: 1150362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of Mercurascan after coronary artery ligation in the dog.
    Málek I; Kolc J; Mrhová O; Urbanová D; Málek P
    Eur J Cardiol; 1980; 12(1):55-62. PubMed ID: 7439234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of mercurascan on some of the metabolic parameters of myocardial ischaemia in the early phases after heart transplantation in the dog (author's transl)].
    Brodan V; Táborský J; Hejnal J; Málek P; Andĕl M
    Cas Lek Cesk; 1979 Apr; 118(14):438-40. PubMed ID: 378375
    [No Abstract]   [Full Text] [Related]  

  • 8. [Velocity of the selective accumulation of Mercurascan 203 in injured muscle and in the ischemic myocardium].
    Málek P; Vavrejn B; Ratuský J; Kronrád L; Kolc J
    Experientia; 1967 Aug; 23(8):649-51. PubMed ID: 6051694
    [No Abstract]   [Full Text] [Related]  

  • 9. Mercurascan test in ischaemia of the heart muscle caused by permanent ligature of the coronary artery.
    Málek P; Kolc J; Vavrejn B; Ratuský J; Kronrád L
    Rev Czech Med; 1971; 17(1):11-5. PubMed ID: 5576153
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta-blockade in experimental myocardial ischaemia: metabolic and electrocardiographic effects.
    Thomas M; Norris R; Opie L; Shulman G; Owen P
    Br Heart J; 1971 Jul; 33(4):609. PubMed ID: 4397629
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolism of Mercurascan-203Hg by rats and dogs.
    Dreyfuss J; Ross JJ; Shaw JM
    J Nucl Biol Med; 1973; 17(2):43-50. PubMed ID: 4754433
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on isoprenaline-induced myocardial lesions. 1. Quantitative evaluation by mercurascan uptake.
    Faltová E; Mráz M; Kronrád L; Protivová L; Sedivý J
    Basic Res Cardiol; 1977; 72(5):454-63. PubMed ID: 588200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of a new diagnostic and antiarrhythmic agent, mercurascan, in experimental myocardial infarct].
    Malek P; Vavreĭn B; Kolts I; Vrana M; Ratuskiĭ I
    Eksp Khir Anesteziol; 1975; (6):3-11. PubMed ID: 1234540
    [No Abstract]   [Full Text] [Related]  

  • 14. Ultrastructural and biochemical alterations induced by propranolol treatment in experimental myocardial ischaemia.
    Laky D; Constantinescu S; Filipescu G; Constantinescu NM; Ratea E; Hălălău F
    Morphol Embryol (Bucur); 1981; 27(3):249-53. PubMed ID: 6460936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental studies in transient myocardial ischaemia.
    Laky D; Constantinescu S; Filipescu G; Constantinescu NM; Ratea E; Halalau F
    Acta Morphol Acad Sci Hung; 1982; 30(3-4):299-307. PubMed ID: 6301225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Possibilities of protecting the ischemic focus in the myocardium].
    Málek I; Kolc J; Mrhová O; Urbanová D; Ratuský J
    Cas Lek Cesk; 1985 Aug; 124(32):1011-4. PubMed ID: 4028084
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of carbochromen on myocardial blood flow and metabolic heat production before and after acute coronary ligation.
    Grayson J; Irvine M; Parratt JR
    Br J Pharmacol; 1969 Oct; 37(2):523P-524P. PubMed ID: 5348445
    [No Abstract]   [Full Text] [Related]  

  • 18. Nifedipine for angina and acute myocardial ischaemia.
    Hugenholtz PG; Verdouw PD; de Jong JW; Serruys PW
    Postgrad Med J; 1983; 59 Suppl 2():40-58. PubMed ID: 6351043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrical instability of the heart in acute local myocardial ischaemia: pathogenesis and experimental prevention.
    Vrána M; Fejfar Z; Vránová Z; Hess L; Blazek Z
    Cor Vasa; 1986; 28(2):114-22. PubMed ID: 2426034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservative management of exomphalos major.
    Merwaha DC; Gupta RL; Gupta RR; Mullick RN
    Indian J Pediatr; 1973 Apr; 40(303):151-3. PubMed ID: 4758009
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.